Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment
February 17, 2022
The CDC’s National Center for Injury Prevention and Control is in the process of updating the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
The draft updated Clinical Practice Guideline for Prescribing Opioids is strong>available for public comment in the Federal Register. The public comment period will be open for 60 days, through April 11, 2022.
The CDC encourages all patients, caregivers, providers, and others who care about safe, effective, and informed pain treatment options to submit their comments via the Federal Register docket.
Please see the CDC’s website detailing the process of updating the Guideline. Encourage people you know who have direct experience with the role of opioids in pain care and the importance of the patient-clinician relationship to visit the Federal Register, review the draft update to the Guideline, and add their perspectives to the Federal Register Notice.
A reminder that BHAP has a tool for looking up who your elected representatives are across the United States so you can contact them about advocacy issues. Free to use regardless of membership, check out our Find Your Rep Tool.
As always, we want your input. What topics would you like to see us cover in future Advocacy Alerts?
Did you know BHAP members get regular access to our advocate in Washington, DC? If you have any questions about BHAP’s advocacy efforts, please contact us.
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.